News

Glioblastoma Pipeline Appears Promising With 200+ Leading Biotech And Pharma Companies Driving Innovation In The Therapeutics Segment Delveinsight
In July 2025, Inovio Pharmaceuticals conducted a Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy ...
China’s Top Medical Device Maker Mindray Is Said to Mull Hong Kong Listing
Shenzhen Mindray Bio-Medical Electronics Co., China’s biggest maker of medical devices, is considering a second listing in ...